Kissei Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
14.23 | 110.63 | -87.13% | 19.4 | -26.64% |
| P/S |
|
2.1 | 75.01 | -97.2% |
|
|
| P/BV |
|
0.7184 | 70.3 | -98.98% |
|
|
| P/FCF |
|
-39.17 | 79.52 | -149.26% |
|
|
| Ev/Ebitda |
|
7.33 | 18.64 | -60.65% |
|
|
| Ev/S |
|
1.82 | 72.39 | -97.49% |
|
|
| Ev/FCF |
|
-39.12 | 24.55 | -259.36% |
|
|
| E/P |
|
0.0812 | -0.1123 | -172.32% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
24.77 | -77.27 | -132.06% | 19.99 | +23.93% |
| ROE |
|
5.39 | -9.19 | -158.65% |
|
|
| ROA |
|
4.63 | -9.6 | -148.22% |
|
|
| ROIC |
|
7.28 | 9.09 | -19.92% |
|
|
| ROS |
|
14.77 | -143.83 | -110.27% |
|
|
| ROCE |
|
5.95 | 6.01 | -1.13% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0716 | -1.04 | -106.87% | 0.1261 | -43.24% |
| Nеt Debt/Ebitda |
|
-1.15 | 12.09 | -109.52% |
|
|
| Debt/Ratio |
|
0.0051 | 0.1394 | -96.32% |
|
|
| Debt/Equity |
|
0.0545 | 18.09 | -99.7% |
|
|
| Debt/Net Income |
|
0.1201 | -1.95 | -106.16% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
8.8/10
|
3.52 | 2.66 | 32.21% | 2.93 | +20.25% |
| Number of years of dividend growth |
|
2 | 1.27 | 57.45% | ||
| DSI |
|
0.9286 | 0.7328 | 26.72% |
|
|
| Average dividend growth |
|
3.06 | -49.62 | -106.16% |
|
|
| Average percentage for 5 years |
|
2.93 | 1.91 | 53.02% |
|
|
| Average percentage for payments |
|
40.14 | 33.37 | 20.29% |
|
|
| Difference from average difference in sector |
|
0.8576 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
19.49 | 53.88 | -63.83% | ||
| Growth impulse Ebitda in 5 years |
|
221.65 | 12.48 | 1676.04% | ||
| Growth impulse Net Income in 5 years |
|
295.74 | -8.53 | -3567.06% | ||
| Growth impulse FCF in 5 years |
|
-127.79 | -13.75 | 829.38% | ||
| Growth impulse EPS in 5 years |
|
308.93 | -67.8 | -555.65% |
IP Score
6.73/10
